The Pregnancy Risks of Ozempic and Wegovy Need More Attention – Vox

Read article - Quotes Steven Woloshin, MED '96, a professor of the Dartmouth Institute, in an article about the pregnancy risks of Ozempic—approved only for diabetes but used off-label for weight loss—as well as the higher-dose obesity formulation Wegovy.